Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride
US5739151A · kind A · utility
25Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 1996 |
| Grant date | Apr 14, 1998 |
| Priority date | — |
| Expiry date | Jul 19, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a method of eliciting an antiemetic effect by administering optically pure (+) isomer of norcisapride.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.